Search clinical trials for: Estrogen receptor positive
Total 29733 results
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
The Methodist Hospital Research InstituteMillennium Pharmaceuticals, Inc.CompletedEstrogen Receptor Positive Breast CancerUnited States
-
Novartis PharmaceuticalsBreast International Group; SOLTI Breast Cancer Research GroupCompletedNeoplasms, BreastFrance, Spain, United Kingdom, Belgium, Argentina, Czechia, Germany, Italy, Norway, Russian Federation, Sweden, Taiwan, Hong Kong, Brazil, Hungary, India, Korea, Republic of, Pakistan, Peru, Romania, South Africa, Ukraine, Canada, Lit...
-
Robert Bosch Gesellschaft für Medizinische Forschung...Completed
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma | Solid CancersUnited States, Spain, France, Canada
-
Eli Lilly and CompanyTerminatedMetastatic Breast CancerUnited States, Puerto Rico
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.; Stand Up To CancerTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Estrogen Receptor-positiveUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Estrogen Receptor Positive TumorSweden
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Endometrial CancerUnited States
-
Taizhou EOC Pharma Co., Ltd.Active, not recruiting
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Genentech, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Spain, Netherlands
-
Pantarhei Oncology B.V.Completed
-
UNICANCERCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Pamela MunsterPfizer; Xynomic Pharmaceuticals, Inc.WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
Loyola UniversityCompletedMetastatic Breast Cancer | Estrogen Receptor Positive | Adult WomenUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Spain, Belgium, Hong Kong, France
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
University of ArkansasOSI PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | Postmenopausal Women | Locally Advanced Metastatic Breast CancerIsrael
-
Yale UniversityNovartis; Genentech, Inc.TerminatedBreast Cancer | Hormone-Sensitive Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdult Solid Tumor | HER2-positive Breast Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, Hungary, Spain, Argentina, Russian Federation, Sweden, Lebanon, Australia, Denmark, Ireland, United Kingdom, Thailand, Turkey, Peru, Brazil, Malaysia, India, United States
-
Novartis PharmaceuticalsCompletedBreast NeoplasmsUnited States, France, Spain, United Kingdom, Croatia, Turkey, Netherlands, Argentina, Australia, Canada, Czechia, Germany, Italy, Poland, Russian Federation, Brazil, Bulgaria, Chile, Denmark, Hungary, Ireland, Peru, South Africa, Col... and more
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
Centre Hospitalier Universitaire de BesanconPierre Fabre MedicamentTerminated
-
Southwest Oncology GroupNovartis; AstraZenecaTerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
The Netherlands Cancer InstituteAstraZenecaSuspendedBreast CancerNetherlands
-
AstraZenecaQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
Gilead SciencesCompletedSolid Tumors and LymphomasUnited States
-
National Cancer Institute (NCI)Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Postmenopausal | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnObesity | Stage I Uterine Corpus Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, United Kingdom, France, Italy, Spain, Turkey, Brazil, India
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Recurrent Ovarian Germ Cell Tumor | Undifferentiated Ovarian Carcinoma | Ovarian Serous...United States
-
Austrian Breast & Colorectal Cancer Study GroupAstraZenecaCompleted
-
Genentech, Inc.Seragon PharmaceuticalsCompletedBreast CancerSpain, United States
-
National University Hospital, SingaporeEisai Co., Ltd.UnknownBreast CancerSingapore
-
Cairo UniversityUnknownBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast CancerEgypt
-
ArQule, Inc. (a wholly owned subsidiary of Merck...TerminatedOvarian Cancer | Endometrial Cancer | Solid TumorsUnited States
-
UNICANCERBreast International GroupCompletedBreast Cancer | Menopause | Estrogen Receptor Positive Tumor | Hormone AntagonistFrance, Sweden, Spain